I don't see why everyone is jumping down sido's throat. Sure he could be more diplomatic about it but nothing really wrong with his reasoning.
As for the success or failure of PRR products, unless you are a doctor or biochemist etc. and have read or had a hand in the research, then really how is that any different from swallowing company PR? Fact is majority small cap biotechs products do not succeed, high risk/reward. PRR may well succeed but I don't understand why there seems to be so much belief vs say the next biotech. They ALL sound promising lol
buyers watchout, page-48
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
-0.005(1.64%) |
Mkt cap ! $436.3M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 31.3¢ | 30.0¢ | $960.6K | 3.161M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 188729 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 46153 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |